Scientific publications for BioPredictive non-invasive diagnostics

Peer-reviewed studies validating BioPredictive blood-test diagnostics for liver disease — from first-in-class development cohorts to long-term meta-analyses.

3/433 Matches for
“paritaprevir/ombitasvir/ritonavir/dasabuvir+Ribavirin”

“paritaprevir/ombitasvir/ritonavir/dasabuvir+Ribavirin” Clear all

  1. Real-world efficacy and safety of ombitasvir, paritaprevir/r+dasabuvir+ribavirin in genotype 1b patients with hepatitis C virus cirrhosis.

    Preda CM et al. · Liver Int · 2018 Match 100

    ### Background Direct antiviral agents (DAA) showed very good results in terms of…

    FibroTest HCV

  2. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Key publication

    AASLD/IDSA HCV Guidance Panel · Hepatology · 2015 Match 84

    ActiTest FibroTest HCV

  3. Management of the patient with SVR. Review

    Terrault NA et al. · J Hepatol · 2016 Match 67

    In the current era of therapy with direct-acting antiviral (DAAs) drugs…

    FibroTest HCV

Showing the full result list. The page is server-rendered and not paginated.